Account
Inquiry
Basically, you're looking at a dual GIP and GLP-1 receptor agonist with a CAS of 2023788-19-2, and what that means in practice is it targets both incretin pathways simultaneously, which gives it an edge over single-pathway compounds like dulaglutide for metabolic research.
It's got a molecular weight of 4813 g/mol — that PEG-modified lysine side chain is what makes it more water-soluble than some of teh older peptides — and we're seeing 99.9% purity via HPLC, which is tighter than what you'll find form most reagent-grade suppilers.
Most buyers go with the 15mg per vial format, and you'll get 10 as the standard pack — the MOQ is 10 vials, not a full box, so our company can split that if you're just starting a pilot study. (usually 2-4 weeks if we've got stock)
Storage is critical here: you want it desiccated at -20°C or below, because peptide backbone degrades noticeably above that after about 30 days or so, and we've seen COAs show a drop to 97% after 60 days at room temp.
It's not ideal for chronic in vivo dosing in higher species without a proper slow-release formulation — the half-life in plasma is short, around 5 days in humans, but for rodent models you'd typically dose daily or every other day depending on your protocol.
Anyway, one thing buyers often miss is that the EC number 200-001-8 applies to the precursor intermediates, not the final peptide itself, so double-check your import paperwork if customs flags that.
Our MOQ is 10 vials, which comes as one box with 10 vials each containing 10 mg of powder.
Lead time is usually 3-5 business days after order confirmation, depending on stock and your location.
Yes, we can supply a COA with each batch that confirms the 99.9% purity and other specs like appearance and molecular weight.
It comes in 10 mg per vial, with 10 vials per box, all sealed for lab use.
This Tirzepatide is pharmacy grade but strictly for research purposes only, not for human or animal use.
